GAP43

Neuromodulin · P17677 · GAP43 on Sugi Atlas →

0 patent compounds predicted against GAP43, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to GAP43 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Does TMS Affect Neuroplasticity? The Role of Brain-derived Neurotrophic Factor and Neuronal Cell Adhesion Molecules - an Intensive Clinical Protocol Among Patients With Obsessive-compulsive Disorders PHASE4COMPLETED
Effect of Oxcarbazepine on Serum Brain Derived Neurotrophic Factor (BDNF) in Bipolar Disorder PHASE4COMPLETED
Evaluating a Nitric Oxide Generator, Nebivolol as a Disease Modifier in Patients With Diabetic Neuropathy. PHASE2/PHASE3RECRUITING
Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia PHASE3COMPLETED
A Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant Depression PHASE3WITHDRAWN
The Synapse Project PHASE2COMPLETED
StereoTactic Arrhythmia Radiotherapy in the NetherLands no. 2 PHASE2RECRUITING
Safety and Efficacy of the PAINLESS Nerve Growth Factor CHF6467 in Optic Pathway Glioma (OPG) PHASE2ACTIVE_NOT_RECRUITING
Comparative Study to Test Safety and Efficacy of Neurotrophic and Cholinergic Treatment of Alzheimer's Disease PHASE2COMPLETED
Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition PHASE2RECRUITING
Cilostazol in Parkinson's Disease PHASE2NOT_YET_RECRUITING
MAD Study of NX210c PHASE1COMPLETED
Gene Therapy for Alzheimer's Disease Clinical Trial PHASE1COMPLETED
Psychoneuromentalism Disorder: A Medical Condition That Affects People With Psychological Impairments From Health Issues EARLY_PHASE1NOT_YET_RECRUITING
Effect of Exercise Gene Expression and Histone Modifications in Patients With Hemiplegia nanRECRUITING
Extracorporeal Shock Wave Therapy Applied to the Plantar Region in Individuals With Hemiplegia nanCOMPLETED
Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins. nanUNKNOWN
Regular Exercise Improves Physical Capacity and Promotes Neurotrophins in Patients With Multiple Sclerosis nanCOMPLETED
Association of Brain Derived Neurotrophic Factor (BDNF) rs6265 Gene Polymorphism With Susceptibility to Epilepsy nanUNKNOWN
Investigation of the Effect of Constraint Induced Movement Therapy Applied to the Lower Extremity on Lower Extremity Functions in Individuals With Unilateral Cerebral Palsy nanENROLLING_BY_INVITATION
Prognostic Value of FP-CIT-SPECT in Parkinson´s Disease nanCOMPLETED
Protein Synthesis in the Brain of Patients With Fragile X Syndrome nanCOMPLETED
Non-Invasive Brain Stimulation to Improve Language in Down Syndrome. nanRECRUITING
Study of the Effect of Antidepressant Drugs on Neurotrophic Factors in Patients With Depression nanCOMPLETED
Relationship of Gestational Age and Urine Concentration of S100B in Preterm and Term Infants in the First Week of Life nanCOMPLETED
Effects of Exercise on Functional Performance, BDNF, Executive Functions and Sleep Quality in Children with Epilepsy nanNOT_YET_RECRUITING
Effects of Preemptive Paracetamol and Ibuprofen on Headache and Myalgia in Patients After Electroconvulsive Therapy nanCOMPLETED
Pre-Emptive Analgesia in Ano-Rectal Surgery nanCOMPLETED
Characterisation of Primary Progressives Aphasias nanUNKNOWN
Predicting Postoperative Delirium Using EEG, Genetics and Neurobiomarkers of Cerebral Injury nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a GAP43 binder may also engage these)

ProteinNameSimilarity
Q95K78 1.000 Q95K78 →
Q5IS67 1.000 Q5IS67 →
Q6S9D9 1.000 Q6S9D9 →
Q5NVP7 1.000 Q5NVP7 →
P06837 1.000 P06837 →
P07936 1.000 P07936 →
P06836 0.998 P06836 →
P35001 0.996 P35001 →
P17691 0.991 P17691 →
P55860 0.990 P55860 →
Q98987 0.989 Q98987 →
P80723 0.978 P80723 →
P80724 0.976 P80724 →
MARCKS Myristoylated alanine-rich C-kinase substrate 0.973 landscape →
P26645 0.973 P26645 →
Q05175 0.972 Q05175 →
Q1RM09 0.971 Q1RM09 →
P23614 0.968 P23614 →
P30009 0.967 P30009 →
Q91XV3 0.967 Q91XV3 →
P16527 0.967 P16527 →
P12624 0.967 P12624 →
Q6PD99 0.966 Q6PD99 →
P43393 0.965 P43393 →
NASP Nuclear autoantigenic sperm protein 0.963 landscape →
P12274 0.961 P12274 →
P05204 0.961 P05204 →
Q2T9P4 0.961 Q2T9P4 →
Q6NWH2 0.959 Q6NWH2 →
P27123 0.958 P27123 →